Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWEEP: HX575 in Anemia of CKD
NCT00869856Phase 3Withdrawn
- Sponsor
- Sandoz
- Start
- Apr 2009
- Primary completion
- Aug 2009
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 5
01
Overview
A Phase 3 trial of epoetin alfa HX575 in anemia of chronic kidney disease (CKD-A), sponsored by Sandoz. Planned start Apr 2009; status: withdrawn.
02
Drugs
epoetin alfa HX575
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00869856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00869856.